2024年J.P. 摩根医疗健康大会PPT合集(共73套打包)

2024年J.P. 摩根医疗健康大会PPT合集(共73套打包)

更新时间:2024-01-21 报告数量:73份

药明生物-JPM-20240110 .pdf   药明生物-JPM-20240110 .pdf
灵北制药-JPM-20240108.pdf   灵北制药-JPM-20240108.pdf
拜耳-JPM-20240109.pdf   拜耳-JPM-20240109.pdf
药明康德-JPM-20240110 .pdf   药明康德-JPM-20240110 .pdf
礼来-JPM-20240109.pdf   礼来-JPM-20240109.pdf
Sarepta-JPM-20240108.pdf   Sarepta-JPM-20240108.pdf
百济-JPM-20240108.pdf   百济-JPM-20240108.pdf
Regeneron-JPM-20240108.pdf   Regeneron-JPM-20240108.pdf
uniQure-JPM-202401.pdf   uniQure-JPM-202401.pdf
Merck-JPM-20240108.pdf   Merck-JPM-20240108.pdf
QIAGEN-JPM-202401.pdf   QIAGEN-JPM-202401.pdf
中国生物制药-JPM-202401 .pdf   中国生物制药-JPM-202401 .pdf
HOLOGIC-JPM-202401.pdf   HOLOGIC-JPM-202401.pdf
Karyopharm Therapeutics-JPM-20240110.pdf   Karyopharm Therapeutics-JPM-20240110.pdf
亚盛医药-JPM-20240110 .pdf   亚盛医药-JPM-20240110 .pdf
赛诺菲-JPM-20240109.pdf   赛诺菲-JPM-20240109.pdf
CytomX Therapeutics-JPM-202401.pdf   CytomX Therapeutics-JPM-202401.pdf
辉瑞-JPM-20240108.pdf   辉瑞-JPM-20240108.pdf
金斯瑞生物-JPM-20240110.pdf   金斯瑞生物-JPM-20240110.pdf
GSK-JPM-20240109.pdf   GSK-JPM-20240109.pdf
Verve-jpm-20240108.pdf   Verve-jpm-20240108.pdf
Biohaven-JPM-20240108.pdf   Biohaven-JPM-20240108.pdf
Vertex-JPM-20240108.pdf   Vertex-JPM-20240108.pdf
Enanta-JPM-20240110.pdf   Enanta-JPM-20240110.pdf
Ultragenyx-JPM-202401.pdf   Ultragenyx-JPM-202401.pdf
Ascendis Pharma-JPM-20240108 .pdf   Ascendis Pharma-JPM-20240108 .pdf
Teva-JPM-20240108 .pdf   Teva-JPM-20240108 .pdf
rocket-JPM-202401.pdf   rocket-JPM-202401.pdf
Coherus-JPM-20240110 .pdf   Coherus-JPM-20240110 .pdf
再鼎医药_JPM_20240108.pdf   再鼎医药_JPM_20240108.pdf
Sage Therapeutics-JPM-202401.pdf   Sage Therapeutics-JPM-202401.pdf
Alnylam-JPM-20240108.pdf   Alnylam-JPM-20240108.pdf
Prime Medicine-JPM-20240108.pdf   Prime Medicine-JPM-20240108.pdf
PTC-JPM-20240108.pdf   PTC-JPM-20240108.pdf
BioAtla-JPM-202401.pdf   BioAtla-JPM-202401.pdf
Incyte-JPM-20240108.pdf   Incyte-JPM-20240108.pdf
Ionis-JPM-20240108.pdf   Ionis-JPM-20240108.pdf
默克-JPM-202401.pdf   默克-JPM-202401.pdf
Arvinas-JPM-202401 .pdf   Arvinas-JPM-202401 .pdf
Denali Therapeutics-JPM-202401.pdf   Denali Therapeutics-JPM-202401.pdf
Gilead-JPM-20240108.pdf   Gilead-JPM-20240108.pdf
Bluebird-JPM-2024.pdf   Bluebird-JPM-2024.pdf
Agios-JPM-20240110.pdf   Agios-JPM-20240110.pdf
Editas Medicine-JPM-202401.pdf   Editas Medicine-JPM-202401.pdf
传奇生物-JPM-202401.pdf   传奇生物-JPM-202401.pdf
Baxter-JPM-20240108.pdf   Baxter-JPM-20240108.pdf
BMS-JPM-20240108.pdf   BMS-JPM-20240108.pdf
Apellis Pharmaceuticals-JPM-20240108 .pdf   Apellis Pharmaceuticals-JPM-20240108 .pdf
Roche-JPM-20240109.pdf   Roche-JPM-20240109.pdf
Beam-JPM-20240108.pdf   Beam-JPM-20240108.pdf
Novartis-JPM-20240108.pdf   Novartis-JPM-20240108.pdf
Argenx-JPM-20240108.pdf   Argenx-JPM-20240108.pdf
ACADIA-JPM-20240109 .pdf   ACADIA-JPM-20240109 .pdf
Jazz Pharmaceuticals-JPM-20240108.pdf   Jazz Pharmaceuticals-JPM-20240108.pdf
Genmab-JPM-20240110.pdf   Genmab-JPM-20240110.pdf
DAIICHI-SANKYO-JPM-20240108.pdf   DAIICHI-SANKYO-JPM-20240108.pdf
BioMarin-JPM-20240108.pdf   BioMarin-JPM-20240108.pdf
AZ-JPM-20240109.pdf   AZ-JPM-20240109.pdf
Amgen-JPM-20240108.pdf   Amgen-JPM-20240108.pdf
JPM 2024 Illumina-1704902051.pdf   JPM 2024 Illumina-1704902051.pdf
JPM 2024 BioNTech-1704871319.pdf   JPM 2024 BioNTech-1704871319.pdf
ONT - JPM FINAL PRESENTATION 9Jan2024.pdf   ONT - JPM FINAL PRESENTATION 9Jan2024.pdf
Revvity-2024JPM_Healthcareconference.pdf   Revvity-2024JPM_Healthcareconference.pdf
jpm-presenter-version-website-version.pdf   jpm-presenter-version-website-version.pdf
JPM-2024-Ginkgo-Bioworks-Final-3.pdf   JPM-2024-Ginkgo-Bioworks-Final-3.pdf
2024-TXG-JPM-Healthcare-Presentation-vF.pdf   2024-TXG-JPM-Healthcare-Presentation-vF.pdf
JPM 2024 Illumina-1704902051.pdf   JPM 2024 Illumina-1704902051.pdf
moderna-2024-jpm-presentation_final-website.pdf   moderna-2024-jpm-presentation_final-website.pdf
JPM 2024 BioNTech-1704871319.pdf   JPM 2024 BioNTech-1704871319.pdf
2024.01.07 Twist Bioscience JPM 2024 FINAL2-website.pdf   2024.01.07 Twist Bioscience JPM 2024 FINAL2-website.pdf
2024 Danaher at JPM Healthcare.pdf   2024 Danaher at JPM Healthcare.pdf
GH-2024-JP-Morgan-Conference-Presentation-Final.pdf   GH-2024-JP-Morgan-Conference-Presentation-Final.pdf
01-09-24-jp-morgan-presentation-final.pdf   01-09-24-jp-morgan-presentation-final.pdf

报告合集目录

报告预览

  • 2024年J.P. 摩根医疗健康大会PPT合集
    • 药明生物-JPM-20240110 .pdf
    • 灵北制药-JPM-20240108.pdf
    • 拜耳-JPM-20240109.pdf
    • 药明康德-JPM-20240110 .pdf
    • 礼来-JPM-20240109.pdf
    • Sarepta-JPM-20240108.pdf
    • 百济-JPM-20240108.pdf
    • Regeneron-JPM-20240108.pdf
    • uniQure-JPM-202401.pdf
    • Merck-JPM-20240108.pdf
    • QIAGEN-JPM-202401.pdf
    • 中国生物制药-JPM-202401 .pdf
    • HOLOGIC-JPM-202401.pdf
    • Karyopharm Therapeutics-JPM-20240110.pdf
    • 亚盛医药-JPM-20240110 .pdf
    • 赛诺菲-JPM-20240109.pdf
    • CytomX Therapeutics-JPM-202401.pdf
    • 辉瑞-JPM-20240108.pdf
    • 金斯瑞生物-JPM-20240110.pdf
    • GSK-JPM-20240109.pdf
    • Verve-jpm-20240108.pdf
    • Biohaven-JPM-20240108.pdf
    • Vertex-JPM-20240108.pdf
    • Enanta-JPM-20240110.pdf
    • Ultragenyx-JPM-202401.pdf
    • Ascendis Pharma-JPM-20240108 .pdf
    • Teva-JPM-20240108 .pdf
    • rocket-JPM-202401.pdf
    • Coherus-JPM-20240110 .pdf
    • 再鼎医药_JPM_20240108.pdf
    • Sage Therapeutics-JPM-202401.pdf
    • Alnylam-JPM-20240108.pdf
    • Prime Medicine-JPM-20240108.pdf
    • PTC-JPM-20240108.pdf
    • BioAtla-JPM-202401.pdf
    • Incyte-JPM-20240108.pdf
    • Ionis-JPM-20240108.pdf
    • 默克-JPM-202401.pdf
    • Arvinas-JPM-202401 .pdf
    • Denali Therapeutics-JPM-202401.pdf
    • Gilead-JPM-20240108.pdf
    • Bluebird-JPM-2024.pdf
    • Agios-JPM-20240110.pdf
    • Editas Medicine-JPM-202401.pdf
    • 传奇生物-JPM-202401.pdf
    • Baxter-JPM-20240108.pdf
    • BMS-JPM-20240108.pdf
    • Apellis Pharmaceuticals-JPM-20240108 .pdf
    • Roche-JPM-20240109.pdf
    • Beam-JPM-20240108.pdf
    • Novartis-JPM-20240108.pdf
    • Argenx-JPM-20240108.pdf
    • ACADIA-JPM-20240109 .pdf
    • Jazz Pharmaceuticals-JPM-20240108.pdf
    • Genmab-JPM-20240110.pdf
    • DAIICHI-SANKYO-JPM-20240108.pdf
    • BioMarin-JPM-20240108.pdf
    • AZ-JPM-20240109.pdf
    • Amgen-JPM-20240108.pdf
    • JPM 2024 Illumina-1704902051.pdf
    • JPM 2024 BioNTech-1704871319.pdf
    • ONT - JPM FINAL PRESENTATION 9Jan2024.pdf
    • Revvity-2024JPM_Healthcareconference.pdf
    • jpm-presenter-version-website-version.pdf
    • JPM-2024-Ginkgo-Bioworks-Final-3.pdf
    • 2024-TXG-JPM-Healthcare-Presentation-vF.pdf
    • JPM 2024 Illumina-1704902051.pdf
    • moderna-2024-jpm-presentation_final-website.pdf
    • JPM 2024 BioNTech-1704871319.pdf
    • 2024.01.07 Twist Bioscience JPM 2024 FINAL2-website.pdf
    • 2024 Danaher at JPM Healthcare.pdf
    • GH-2024-JP-Morgan-Conference-Presentation-Final.pdf
    • 01-09-24-jp-morgan-presentation-final.pdf
请点击导航文件预览
资源包简介:

1、9 January 2024JPM 2024Gordon Sanghera,CEO 2024 Oxford Nanopore Technologies plc.Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose,treat,mitigate,cure。

2、J.P.Morgan42ndHealthcare ConferencePrahlad SinghChief Executive OfficerJanuary 9,2024Safe HarborThis presentation contains forward-looking statements which are statements relating to future events.Th。

3、EXACT SCIENCES1We aim to help eradicate cancer by preventing it,detecting it earlier,and guiding personalized treatment.J.P.Morgan Health Care Conference 2024January 8,2024EXACT SCIENCES2#1cause of d。

4、Ginkgo Bioworks JP Morgan Conference 2024Property of Ginkgo Bioworks 1Grow with GinkgoJ.P.Morgan Healthcare ConferenceJason KellyCo-Founder&CEOJanuary 10,20241Ginkgo Bioworks JP Morgan Conference。

5、Accelerating the Mastery of Biology to Advance Human Health42nd Annual J.P.Morgan Healthcare ConferenceSerge SaxonovCEO and Co-founder 10X GENOMICS,INC.20242 2Certain statements in this presentation 。

6、 2024 Illumina,Inc.All rights reserved.CEO,IlluminaJacob Thaysen,Ph.D.42nd Annual J.P.Morgan Healthcare ConferenceJanuary 9,2024Note Regarding GRAILThe European Commission issued a decision to prohib。

7、42nd J.P.Morgan Healthcare ConferenceProf.Ugur Sahin,M.D.CEO&Co-founder9 January 20249:00 9:40 AM PSTThis Slide Presentation Includes Forward-Looking Statements2This presentation contains forward。

8、Writing the FutureJ A N U A R Y 2 0 2 4|TWIST BIOSCIENCE Legal DisclaimersThis presentation contains forward-looking statements.All statements other than statements of historical facts contained here。

9、Danaher CorporationRainer Blair,President&CEOJ.P.Morgan Healthcare Conference|January 9,20242Forward Looking StatementsStatements in this presentation that are not strictly historical,including a。

10、Transforming Cancer CareJ.P.Morgan Healthcare ConferenceJanuary 8,2024Safe harbor2Certain statements in this presentation and the accompanying oral commentary are forward-looking statements within th。

11、The world leader in serving scienceMarc N.CasperChairman,President and Chief Executive Officer42nd Annual J.P.MorganHealthcare ConferenceJanuary 9,2024Safe Harbor/Non-GAAP Measures2Various remarks th。

展开阅读全文
客服
商务合作
小程序
服务号
折叠